These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 11992417)

  • 1. Adenovirus HSV-TK construct with thyroid-specific promoter: enhancement of activity and specificity with histone deacetylase inhibitors and agents modulating the camp pathway.
    Kitazono M; Chuman Y; Aikou T; Fojo T
    Int J Cancer; 2002 May; 99(3):453-9. PubMed ID: 11992417
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Construction of gene therapy vectors targeting thyroid cells: enhancement of activity and specificity with histone deacetylase inhibitors and agents modulating the cyclic adenosine 3',5'-monophosphate pathway and demonstration of activity in follicular and anaplastic thyroid carcinoma cells.
    Kitazono M; Chuman Y; Aikou T; Fojo T
    J Clin Endocrinol Metab; 2001 Feb; 86(2):834-40. PubMed ID: 11158054
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transcriptional activation of the thyroglobulin promoter directing suicide gene expression by thyroid transcription factor-1 in thyroid cancer cells.
    Shimura H; Suzuki H; Miyazaki A; Furuya F; Ohta K; Haraguchi K; Endo T; Onaya T
    Cancer Res; 2001 May; 61(9):3640-6. PubMed ID: 11325833
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adenoviral-mediated gene therapy for thyroid carcinoma using thymidine kinase controlled by thyroglobulin promoter demonstrates high specificity and low toxicity.
    Zhang R; Straus FH; DeGroot LJ
    Thyroid; 2001 Feb; 11(2):115-23. PubMed ID: 11288980
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tumor-specific gene therapy for undifferentiated thyroid carcinoma utilizing the telomerase reverse transcriptase promoter.
    Takeda T; Inaba H; Yamazaki M; Kyo S; Miyamoto T; Suzuki S; Ehara T; Kakizawa T; Hara M; DeGroot LJ; Hashizume K
    J Clin Endocrinol Metab; 2003 Aug; 88(8):3531-8. PubMed ID: 12915632
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regression of hepatocellular carcinoma in vitro and in vivo by radiosensitizing suicide gene therapy under the inducible and spatial control of radiation.
    Kawashita Y; Ohtsuru A; Kaneda Y; Nagayama Y; Kawazoe Y; Eguchi S; Kuroda H; Fujioka H; Ito M; Kanematsu T; Yamashita S
    Hum Gene Ther; 1999 Jun; 10(9):1509-19. PubMed ID: 10395376
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A tandemly repeated thyroglobulin core promoter has potential to enhance efficacy for tissue-specific gene therapy for thyroid carcinomas.
    Takeda T; Yamazaki M; Minemura K; Imai Y; Inaba H; Suzuki S; Miyamoto T; Ichikawa K; Kakizawa T; Mori J; DeGroot LJ; Hashizume K
    Cancer Gene Ther; 2002 Oct; 9(10):864-74. PubMed ID: 12224028
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Construction and identification of recombinant vectors carrying herpes simplex virus thymidine kinase genes expressed in vascular endothelial cells].
    Liu XP; Li BJ; Zhang C
    Ai Zheng; 2006 Feb; 25(2):179-84. PubMed ID: 16480582
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transcriptionally targeted retroviral vector for combined suicide and immunomodulating gene therapy of thyroid cancer.
    Barzon L; Bonaguro R; Castagliuolo I; Chilosi M; Gnatta E; Parolin C; Boscaro M; Palù G
    J Clin Endocrinol Metab; 2002 Nov; 87(11):5304-11. PubMed ID: 12414907
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of tumor growth by direct intratumoral gene transfer of herpes simplex virus thymidine kinase gene with DNA-liposome complexes.
    Sugaya S; Fujita K; Kikuchi A; Ueda H; Takakuwa K; Kodama S; Tanaka K
    Hum Gene Ther; 1996 Jan; 7(2):223-30. PubMed ID: 8788173
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Overexpression of TTF-1 and PAX-8 restores thyroglobulin gene promoter activity in ARO and WRO cell lines.
    Chun YS; Saji M; Zeiger MA
    Surgery; 1998 Dec; 124(6):1100-5. PubMed ID: 9854590
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A thyroid-specific far-upstream enhancer in the human sodium/iodide symporter gene requires Pax-8 binding and cyclic adenosine 3',5'-monophosphate response element-like sequence binding proteins for full activity and is differentially regulated in normal and thyroid cancer cells.
    Taki K; Kogai T; Kanamoto Y; Hershman JM; Brent GA
    Mol Endocrinol; 2002 Oct; 16(10):2266-82. PubMed ID: 12351692
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Targeted expression of herpes simplex virus thymidine kinase in adenovirus-infected cells reduces virus titers upon treatment with ganciclovir in vitro.
    Ibrišimović M; Nagl U; Kneidinger D; Rauch M; Lion T; Klein R
    J Gene Med; 2012 Jan; 14(1):3-19. PubMed ID: 22190534
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of histone acetylation on sodium iodide symporter promoter and expression of thyroid-specific transcription factors.
    Puppin C; D'Aurizio F; D'Elia AV; Cesaratto L; Tell G; Russo D; Filetti S; Ferretti E; Tosi E; Mattei T; Pianta A; Pellizzari L; Damante G
    Endocrinology; 2005 Sep; 146(9):3967-74. PubMed ID: 15919754
    [TBL] [Abstract][Full Text] [Related]  

  • 15. TATA-dependent enhancer stimulation of promoter activity in mice is developmentally acquired.
    Majumder S; DePamphilis ML
    Mol Cell Biol; 1994 Jun; 14(6):4258-68. PubMed ID: 8196662
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Retrovirus-mediated herpes simplex virus thymidine kinase gene transduction renders human thyroid carcinoma cell lines sensitive to ganciclovir and radiation in vitro and in vivo.
    Nishihara E; Nagayama Y; Mawatari F; Tanaka K; Namba H; Niwa M; Yamashita S
    Endocrinology; 1997 Nov; 138(11):4577-83. PubMed ID: 9348181
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Histone deacetylase inhibitor depsipeptide represses nicotinamide N-methyltransferase and hepatocyte nuclear factor-1beta gene expression in human papillary thyroid cancer cells.
    Xu J; Hershman JM
    Thyroid; 2006 Feb; 16(2):151-60. PubMed ID: 16676400
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reexpression of thyroid peroxidase in a derivative of an undifferentiated thyroid carcinoma cell line by introduction of wild-type p53.
    Fagin JA; Tang SH; Zeki K; Di Lauro R; Fusco A; Gonsky R
    Cancer Res; 1996 Feb; 56(4):765-71. PubMed ID: 8631011
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [A study on selective killing effect of Hsv-tk/GCV driven by human telomerase catalytic subunit promoter on human lung cancer cell A549].
    Tang XJ; Wang YP; Zhou QH; Che GW; Chen XH; Zhu DX
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2007 Apr; 24(2):148-52. PubMed ID: 17407070
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The insulinoma-associated 1: a novel promoter for targeted cancer gene therapy for small-cell lung cancer.
    Pedersen N; Pedersen MW; Lan MS; Breslin MB; Poulsen HS
    Cancer Gene Ther; 2006 Apr; 13(4):375-84. PubMed ID: 16052225
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.